Buy, Sell, Or Hold Johnson & Johnson Stock At $140?

Buy, Sell, Or Hold Johnson & Johnson Stock At $140?

Johnson & Johnson (NYSE: JNJ) stock has declined 2% since the beginning of this year (through April 8), compared to a 15% decline for the broader S&P 500.. Despite the outperformance, we believe that Johnson & Johnson's stock has a significant upside from the current levels of around $140.. The stock price didn't gain over the past two years despite steady revenue growth for the company.. For comparison, on an adjusted basis, Johnson & Johnson's EPS grew 19% between 2017 and 2019.. We believe there is a potential upside for Johnson & Johnson's multiple when compared to levels seen over recent years - P/E of 25x at the end of 2019, and 24x currently.. We believe Johnson & Johnson's Q1 results next week will confirm the trend in revenues.. Going by historical trends, we believe that the company's stock is currently oversold and offers potential upside returns.. Led by MIT engineers and Wall Street analysts, Trefis (through its dashboards platform dashboards.trefis.com) helps you understand how a company's products, that you touch, read, or hear about everyday, impact its stock price..